Controlling the state of a cell in a desired direction is one of the central challenges in life sciences, including drug development, cancer treatment, and regenerative medicine.

The FDA's rejections of Replimune and Capricor therapies show how instability threatens biotech innovation, CEOs say.

Researchers from NUS have pioneered a photocatalytic atom-swapping transformation that converts oxetanes into a variety of four-membered saturated cyclic molecules, which are key scaffolds in ...

AI has advanced molecule design, yet synthetic feasibility remains a bottleneck. Chemistry-first approaches offer a practical ...

Every hospital shelf and pharmacy counter depends on an invisible global current, the pharmaceutical supply chain. Yet this ...

Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and ...

After walking away from cell therapy and narrowing its focus to just three modalities, Takeda is doubling down on its ...

This study reviewed all industry-sponsored phase I clinical trial protocols activated at one of eight Sarah Cannon Research Institute drug development units between 2021 and 2024. The review focused ...

While there's growing evidence that psychedelic drugs can effectively treat severe mental health conditions, especially in cases where traditional treatments have failed, they still come with ...

The Arleigh Burke-class guided missile destroyer USS Cole transits through the Caribbean Sea, July 22, 2025. Credit: U.S. Navy photo by Mass Communication Specialist 2nd Class Rylin Paul The “targeted ...

Rollout of NativeLink and ProTrigger products for next-generation antibody conjugates, plus an ADC therapeutic discovery collaboration with a leading biotech, highlight early momentum PALO ALTO, Calif ...

In light of thereported use of marijuanain the Senate, Sen. Migz Zubiri undergoes drug testing, hoping that his colleagues will take his lead and promote a drug-free Senate. Joanne Woodward, the ...